STOCK TITAN

Liquidia to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) announced that CEO Damian deGoa will present at the H.C. Wainwright 23rd Annual Global Investment Conference, scheduled for September 13-15, 2021. The presentation will be virtual and available on-demand in the Investors section of Liquidia's website starting at 7:00 a.m. ET on September 13, 2021. It will remain accessible for 30 days post-conference. Liquidia focuses on the development of products for pulmonary hypertension using its PRINT® Technology.

Positive
  • None.
Negative
  • None.

MORRISVILLE, N.C., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Damian deGoa, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, which runs from September 13 – 15, 2021. The conference will be held in a virtual format.

The presentation will be available on-demand in the Investors section of Liquidia’s website at https://liquidia.com/investors/events-and-presentations starting at 7:00 a.m. ET on Monday, September 13, 2021, and available for 30 days following the conference.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies is developing LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection. For more information, please visit www.liquidia.com.

Contact Information

Media & Investors:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com


FAQ

When will Liquidia Corporation present at the H.C. Wainwright conference?

Liquidia Corporation will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021.

How can I access Liquidia's presentation from the conference?

Liquidia's presentation will be available on-demand on their website starting at 7:00 a.m. ET on September 13, 2021.

What is Liquidia Corporation's focus area?

Liquidia Corporation focuses on developing and commercializing products for pulmonary hypertension and other applications using its PRINT® Technology.

How long will Liquidia's conference presentation be available?

The conference presentation will be available for 30 days after the event.

Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Stock Data

912.38M
60.46M
19.49%
54.31%
12.25%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MORRISVILLE